Is SELLAS Life Sciences Group, Inc (SLS) Stock Halal or Haram?
SELLAS Life Sciences Group, Inc (SLS) - Not Halal (Non-Compliant)
SELLAS Life Sciences Group, Inc (SLS) is classified as Not Halal (Non-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
Sector
Healthcare
Industry
Biotechnology
Result
Pass
Reason
The sector "Healthcare" and industry "Biotechnology" are not in the excluded categories.
Financial Ratios
Debt Ratio
Value: 0.1% | Threshold: 30% | Result: Pass
Cash & Interest-bearing Securities Ratio
Value: 18.2% | Threshold: 30% | Result: Pass
Non-Permissible Income Ratio
Value: 31.7% | Threshold: 5% | Result: Fail
Dividend Purification
Purification percentage: 31.70%.Based on the company's financial statements, approximately 31.70% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (31.70% of total income). Some scholars may differ on the exact calculation method.
About SELLAS Life Sciences Group, Inc
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Frequently Asked Questions
Is SELLAS Life Sciences Group, Inc (SLS) stock halal to invest in?
Based on the company's financial statements, approximately 31.70% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (31.70% of total income). Some scholars may differ on the exact calculation method.
Uses quarterly data
About SELLAS Life Sciences Group, Inc
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
United StatesNASDAQHealthcare
Screened using AAOIFI Standard No. 21 on October 28, 2026. Financial ratios compared against market capitalization. Different methodologies may produce different results. Learn how we screen.
Screened using AAOIFI Shariah Standard No. 21 (3 ratios). Debt and interest-bearing deposits must each be under 30% of market capitalization, and non-permissible income under 5% of total income. This screening is for educational purposes only and does not constitute a fatwa or religious ruling. Results are based on publicly available financial data and automated analysis. Users should consult qualified Islamic scholars and financial advisors for personal investment decisions. Financial data may be delayed or incomplete. Past compliance does not guarantee future status.
Verdict history
Free with an account.
No verdict changes recorded since first screened on Oct 28, 2026. We started recording changes on Oct 28, 2026.
Dates are when Mizaan recorded the change. Tracked and watched stocks are re-checked weekly; other stocks are re-screened on demand.
Get More on the Mizaan App
Live charts, market cap, financials, AI business analysis, portfolio tracking, and compliance alerts — all on your phone.
Frequently Asked Questions
According to AAOIFI Shariah screening standards, SELLAS Life Sciences Group, Inc (SLS) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.
Identified interest income is 31.7% of SELLAS Life Sciences Group, Inc's total income. AAOIFI standards require non-permissible income to be below 5%.
SLS is screened using AAOIFI Standard No. 21, which involves two checks: business activity screening (ensuring the company's core business is permissible in Islam) and financial ratio screening (checking debt, interest income, and cash ratios against defined thresholds). AAOIFI is the most widely recognized standard for Islamic finance.
SELLAS Life Sciences Group, Inc's compliance status is reviewed whenever new financial data becomes available, typically after quarterly or annual earnings reports. Market cap changes can also affect financial ratio screening results. Mizaan refreshes screening data periodically to reflect the latest filings.
Watch SLS free with a Mizaan account. Watched stocks are re-checked weekly, and any verdict change is dated in the verdict history on this page. Premium members also get an alert when it changes.
Approximately 31.70% of dividend income from SELLAS Life Sciences Group, Inc comes from non-permissible sources such as interest income. Many investors purify that share by donating it to charity; scholars differ on the details, so check with one you trust.
Yes, Zakat is generally due on stock holdings. The calculation depends on your school of thought (madhab) and whether you hold shares for trading or long-term investment. Use Mizaan's Zakat calculator to compute your obligation based on your specific madhab and holding intent.
According to AAOIFI Shariah screening standards, SELLAS Life Sciences Group, Inc (SLS) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.
Does SELLAS Life Sciences Group, Inc have any interest income?
Identified interest income is 31.7% of SELLAS Life Sciences Group, Inc's total income. AAOIFI standards require non-permissible income to be below 5%.
What guidelines are used to determine if SLS stock is Shariah-compliant?
SLS is screened using AAOIFI Standard No. 21, which involves two checks: business activity screening (ensuring the company's core business is permissible in Islam) and financial ratio screening (checking debt, interest income, and cash ratios against defined thresholds). AAOIFI is the most widely recognized standard for Islamic finance.
How often is SELLAS Life Sciences Group, Inc stock reviewed for Shariah compliance?
SELLAS Life Sciences Group, Inc's compliance status is reviewed whenever new financial data becomes available, typically after quarterly or annual earnings reports. Market cap changes can also affect financial ratio screening results. Mizaan refreshes screening data periodically to reflect the latest filings.
How can I stay updated on SELLAS Life Sciences Group, Inc's compliance status?
Watch SLS free with a Mizaan account. Watched stocks are re-checked weekly, and any verdict change is dated in the verdict history on this page. Premium members also get an alert when it changes.
Are dividends from SELLAS Life Sciences Group, Inc stock considered halal?
Approximately 31.70% of dividend income from SELLAS Life Sciences Group, Inc comes from non-permissible sources such as interest income. Many investors purify that share by donating it to charity; scholars differ on the details, so check with one you trust.
Do I need to pay Zakat on my SELLAS Life Sciences Group, Inc shares?
Yes, Zakat is generally due on stock holdings. The calculation depends on your school of thought (madhab) and whether you hold shares for trading or long-term investment. Use Mizaan's Zakat calculator to compute your obligation based on your specific madhab and holding intent.
